Briefs DNA’s smoking gun Weizmann scientists and UK colleagues have devised a new lung cancer screening protocol based on a simple blood test that measures the ability of cells to respond to genetic damage. Date: October 3, 2019
In the media The New York Times Gilead buys Kite Pharma for $11.9 billion; Kite is based on the immunotherapy breakthroughs of Prof. Zelig Eshhar. Date: August 28, 2017
Features A lab of her own The Israel National Postdoctoral Award Program for Women in Science, initiated by the Weizmann Institute a decade ago, is helping give women scientists the leverage they need to compete for faculty-track positions in Israeli academia. Date: October 18, 2017
